biomedicina slovenica


"Cyclophosphamide" : 177

  1. Rožman Samo; Jezeršek Novaković Barbara; Ružić Gorenjec Nina; Novaković Srdjan
    Treatment outcomes and relative dose intensity of chemotherapy in patients with advanced Hodgkin lymphoma
    2022
  2. Peskar Dominika; Kuret Tadeja; Jeruc Jera; Erman Andreja
    Lectins as biomarkers of IC/BPS disease
    2022
  3. Veitch Zachary; Khan Omar F.; Tilley Derek; Tang Patricia; Ribnikar Domen; Stewart Douglas A.; Kostaras Xanthoula; King Karen; Lupichuk Sasha
    Impact of cumulative chemotherapy dose on survival with adjuvant FEC-D chemotherapy for breast cancer
    2019
  4. Veitch Zachary; Khan Omar F.; Tilley Derek; Ribnikar Domen; Kostaras Xanthoula; King Karen; Tang Patricia; Lupichuk Sasha
    Real-world outcomes of adjuvant chemotherapy for node-negative and node-positive HER2-positive breast cancer
    2019
  5. Hočevar Alojzija; Tomšič Matija; Perdan-Pirkmajer Katja
    Clinical approach to diagnosis and therapy of polyarteritis nodosa
    2021
  6. Pudil Radek; Mueller Christian; Čelutkienè Jelena; Lenihan Dan; Dent Susan; Barac Ana; Stanway Susanna; Anker Marcus S.; Seferović Petar M.; Lainščak Mitja
    Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies
    2020
  7. Ramos-Casals Manuel; Brito-Zeron Pilar; Bombardieri Stefano; Bootsma Hendrika; De Vita Salvatore; Dörner Thomas; Fisher Benjamin; Gottenberg Jacques-Eric; Hernandez-Molina Gabriela; Kocher Agnes; Praprotnik Sonja
    EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
    2020
  8. Škerget Matevž; Skopec Barbara; Žontar Darja; Černelč Peter
    Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    2016
  9. Damjanov Nemanja; Pavlov Slavica; Djordjević-Kontić Slobodanka; Novičić-Šašić Dara; Josipović Božo; Radunović Goran; Ostojić Predrag
    Cyclophosphamide pulse therapy in systemic sclerosis with interstitial lung disease
    2000
  10. Horvat Matej; Zadnik Vesna; Južnič Šetina Tanja; Boltežar Lučka; Pahole Goličnik Jana; Novaković Srdjan; Jezeršek Novaković Barbara
    Diffuse large B-cell lymphoma
    2018
  11. Erman Andreja; Hudoklin Samo; Zupančič Daša; Romih Rok; Perše Martina
    Effects of single dose of cyclophosphamide in young and old mice
    2017
  12. Rožman Samo; Grabnar Iztok; Novaković Srdjan; Mrhar Aleš; Jezeršek Novaković Barbara
    Population pharmacokinetics of rituximab in patients with diffuse large B-cell lymphoma and association with clinical outcome
    2017
  13. Bonnefoi Herve; Jacot W.; Saghatchian M.; Moldovan C.; Venat-Bouvet L.; Zaman Khurshid; Matos Erika; Petit T.; Bodmer A.; Quenel-Tueux N.; Chakiba C.
    Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer
    2015
  14. Mravljak Marija; Lindič Jelka
    Napovedni dejavniki uspešnosti zdravljenja z nizko odmerjenimi pulzi ciklofosfamida pri bolnikih s sistemskim vaskulitisom s pozitivnimi protitelesi proti citoplazemskim antigenom nevtrofilnih granulocitov (ANCA)
    2015
  15. Rožman Samo; Novaković Srdjan; Grabnar Iztok; Cerkovnik Petra; Jezeršek Novaković Barbara
    The impact of FcyRIIa and FcyRIIIa gene polymorphisms on responses to RCHOP chemotherapy in diffuse large B-cell lymphoma patients
    2016
  16. Savšek Lina; Roš-Opaškar Tanja
    Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
    2016
  17. Boltežar Lučka; Pintarić Karlo; Jezeršek Novaković Barbara
    Fertility in young patients following treatment for Hodgkin's lymphoma
    2016
  18. Čufer Tanja
    Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality
    2014
  19. Lee Gilho; Romih Rok; Zupančič Daša
    Cystitis
    2014
  20. Mravljak Marija; Pajek Jernej; Kovač Damjan; Vizjak Alenka; Ferluga Dušan; Aleš Andreja; Kveder Radoslav; Škoberne Andrej; Večerić-Haler Željka; Košir Andrej; Bren Andrej; Lindič Jelka
    Vrsta proteinurije kot napovednik uspešnosti zdravljenja bolnikov s sistemskim ANCA vaskulitisom s pulzi cikofosfamida
    [Type of proteinuria as predictor of successful treatment with cyclophosphamide pulse therapy in patients with systemic anca vasculitis]
    2014
  21. Koželj Mirta; Zver Samo; Zadnik Vesna
    Long term follow-up report of cardiac toxicity in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
    2013
  22. Harbeck Nadia; Čufer Tanja; Borštnar Simona
    Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
    2013
  23. Černelč Peter; Kodre Veronika
    Zdravljenje starejšega bolnika z ugodno napovedjo poteka diseminiranega plazmocitoma
    [Effectiveness of treatment of an elderly patient with good prognosis of multiple myeloma]
    2012
  24. Meier FM; Frommer KW; Dinser R; Rozman B
    Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
    2012
  25. Kopač Matjaž; Meglič Anamarija; Rus Rina
    Partial remission of resistant nephrotic syndrome after oral galactose therapy
    2011
  26. Gregorič Brigita; Zadnik Vesna; Jezeršek-Novaković Barbara
    The diffuse large B-cell lymphoma - where do we stand now in everyday clinical practice
    [Difuzni velikocelični limfom B - današnja vsakodnevna klinična praksa]
    2012
  27. Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Čufer T
    Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy
    2012
  28. Zupančič Daša; Zakrajšek Maja; Zhou Ge; Romih Rok
    Expression and localization of four uroplakins in urothelial preneoplastic lesions
    2011
  29. Bonnefoi Herve; Piccart Martine; Bogaerts Jan; Čufer Tanja
    TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
    2011
  30. Slamon Denis; Eiermann Wolfgang; Robert Nicholas; Pienkowski Tadeusz; Martin Miguel; Press Michael; Mackey John; Matos Erika; Čufer Tanja; Takač Iztok
    Adjuvant trastuzumab in HER2-positive breast cancer
    2011
  31. Perdan-Pirkmajer K; Koren-Kranjc M; Tomšič M
    A successfully treated pancreatitis caused by a CMV infection in a lupus patient
    2011
  32. Remškar Zlata
    Diferencialno diagnostična analiza primera bolnika z bilateralnimi pljučnimi infiltrati, hipoksemijo in hemoptizami
    [Differential diagnosis in a patient with bilateral pulmonary infiltrates, hypoxemia and hemoptysis]
    2009
  33. Lindič Jelka; Vizjak Alenka; Ferluga Dušan; Kovač Damjan; Aleš Andreja; Kveder R; Ponikvar R; Bren A
    Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane
    2009
  34. Zupančič Daša; Vidmar Gaj; Jezernik Kristijan
    Melatonin prevents the development of hyperplastic urothelium induced by repeated doses of cyclophosphamide
    2009
  35. Hudoklin Samo; Zupančič Daša; Romih Rok
    Maturation of the Golgi apparatus in urothelial cells
    2009
  36. Gruber G; Cole BF; Castiglione-Gertsch M; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Thurlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Price KN; Goldhirsch A; Viale G; Gusterson BA; Eržen D; Čufer T; Majdič E; Štabuc B; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Novak J; Naglas M; Senčar M; Červek J; Šebek S; Cerar O; Plesničar A; Zakotnik B
    Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
    2008
  37. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009
  38. Viale Giuseppe; Golouh Rastko
    Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
    2008
  39. Koželj Mirta; Zver Samo; Zadnik Vesna; Černelč Peter
    Echocardiographic assessment of the cardiac toxicity of high dose cyclophosphamide and melphalan
    [Ehokardiografska ocena toksičnosti visokih odmerov ciklofosfamida in melfalana]
    2008
  40. Mencinger Marina; Černelč Peter
    Preprečevanje bakterijskih in glivičnih okužb pri bolnikih z diseminiranim plazmocitomom, ki prejmejo ciklofosfamid za mobilizacijo krvotvornih matičnih celic
    [Antimicrobial and antifungal propxylaxis in patients with multiple myeloma, that receive cyclophosphamide for mobilization of hematopoietic stem cells]
    2008
  41. Zupančič Daša; Jezernik Kristjan; Vidmar Gaj
    Effect of melatonin on apoptosis, proliferation and differentiation of urothelial cells after cyclophosphamide treatment
    2008
  42. Zver Samo; Zadnik Vesna; Bunc Matjaž; Rogel Polona; Černelč Peter; Koželj Mirta
    Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    2007
  43. Zver S; Bunc M; Brvar M; Koželj M
    Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma
    2007
  44. Zver Samo
    Kardiotoksičnost velikih odmerkov ciklofosfamida in melfalana pri zdravljenju bolnikov z diseminiranim plazmocitomom
    2007
  45. Zver S; Bunc M; Brvar M; Koželj M
    Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma
    2007
  46. Zupančič Daša
    Zaščitna vloga melatonina pri poškodbi in obnovi urotelija po delovanju ciklofosfamida
    2006
  47. Božič B; Rozman B; Tomšič M; Kveder T
    Acquired myopathies
    2006
  48. Gruber Guenther; Bonetti Marco; Nasi Laura M; Price Karen; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Holmberg Stig B; Lindtner Jurij; Golouh Rastko; Collins John
    Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from international breast cancer study group trial VI
    2005
  49. Romih Rok; Erdani-Kreft Mateja; Jezernik Kristijan
    Changes of sugar residues in the apical plasma membrane during differentiation of superficial urothelial cells
    2006
  50. Veranič Peter; Jezernik Kristijan
    The cytokeratins of urinary bladder epithelial cells
    2006
  51. Pleterski Dita
    Spremljanje neželenih učinkov kemoterapije pri bolnikih z drobnoceličnim pljučnim rakom
    [Monitoring adverse reactions of chemotherapy on patients with small cell lung cancer]
    2005
  52. Polenčič Aljoša; Popović Mara; Vodušek David B
    Primarni vaskulitis osrednjega živčevja, omejen na možgansko deblo
    [Primary vasculitis of the CNS restricted to the brainstem]
    2005
  53. Veranič Peter; Romih Rok; Jezernik Kristijan
    Formation of the cytokeratin network in superficial urothelial cells during differentiation
    2005
  54. Romih Rok
    Maturation of asymmetric unit membrane during urothelial cell differentiation
    2005
  55. Veranič Peter; Romih Rok; Jezernik Kristijan
    Regeneration of urothelium after application of cyclophosphamide
    2004
  56. Nečas M; Semradova V; Vašku V
    Pyoderma gangraenosum associated with autoimmune thyreopathy and hyperandrogenic syndrome
    2005
  57. Zaletel-Zadravec Lorna; Bratanič N; Jereb Berta
    Gonadal function in patients treated for leukemia in childhood
    2004
  58. Efficace Fabio; Therasse Patrick; Piccart Martine J; Coens Corneel; van Steen Kristel; Welnicka-Jaskiewicz Marzena; Čufer Tanja; Dyczka Jaroslaw; Lichinitser Michail; Shepherd Lois
    Health-related quality of life parameters as prognostic factors in a nonmestatic breast cancer population: an international multicenter study
    2004
  59. Bottomley Andrew; Biganzoli Laura; Čufer Tanja; Coleman Robert E; Coens Cornel; Efficace Fabio; Calvert Hilary Allan; Gamucci Teresa; Twelves Chris; Fargeot Pierre; Piccart Martine
    Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European organization for research and treatment of cancer breast cancer group, Investigational drug branch for breast cancer and the New drug development group study
    2004
  60. Takač Iztok; Arko Darja; Bali Robert; Čas-Sikošek Nina; Gorišek Borut
    The study "Breast cancer international research group (BCIRG) 005"
    2004
  61. Takač Iztok
    Research work at the Department of gynecologic and breast oncology of Maribor teaching hospital
    2004
  62. Reich A; Szepietowski JC; Bialynicki-Birula R; Czarnecki R
    Bullous pemphigoid in a patient with giant squamous cell carcinoma of the groin
    2004
  63. Yee C-S; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O
    EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis
    2004
  64. Atalay G; Biganzoli L; Renard F; Paridaens R; Čufer T; Coleman R; Calvert AH; Gamucci T; Minisini A; Therasse P
    Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials
    2003
  65. Goldhirsch A; Lindtner J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial
    2003
  66. Černelč Peter; Tomažič Janez
    Zdravljenje krvavitev in protiteles za FVIII pri bolnikih s pridobljeno hemofilijo A
    [Treatment of bleeding and factor VIII inhibitors in acquired hemophilia A patients]
    2004
  67. Veranič Peter; Romih Rok; Jezernik Kristijan
    What determines differentiation of urothelial umbrella cells?
    2004
  68. Aebi S; Gelber S; Castiglione-Gertsch M; Gelber RD; Collins J; Thurlimann B; Rudenstam CM; Lindtner J
    Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
    2000
  69. Colleoni M; Litman HJ; Castiglione-Gertsch M; Sauerbrei W; Gelber RD; Bonetti M; Coates AS; Schumacher M; Bastert G; Lindtner J
    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
    2002
  70. Spataro Vito J; Litman Heather; Viale Giuseppe; Maffini Fausto; Masullo Michele; Golouh Rastko; Lindtner Jurij
    Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from international breast cancer study group trial V
    2003
  71. Jezernik Kristijan; Romih Rok; Mannherz Hans Georg; Koprivec Daša
    Immunohistochemical detection of apoptosis, proliferation and inducible nitric oxide synthase in rat urothelium damaged by cyclophosphamide treatment
    2003
  72. Tomšič Matija
    Imunomodulirajoča zdravila
    2003
  73. Rozman Blaž
    Idiopatični vaskulitisi
    2003
  74. Therasse P; Mauriac L; Welnicka-Jaskiewicz M; Bruning P; Čufer T; Bonnefoi H; Tomiak E; Pritchard KI; Hamilton A; Piccart MJ
    Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study
    2003
  75. Bonnefoi H; Biganzoli L; Mauriac L; Čufer T; Schaefer P; Atalay G; Piccart M
    An EORTC phase I study of capecitabine (xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer
    2003
  76. Praprotnik Sonja; Tomšič Matija
    Zdravljenje bolnic z revmatično boleznijo v nosečnosti
    [Treatment strategy of the rheumatic disease during pregnancy]
    2003
  77. Kveder Radoslav
    Therapy-resistant focal and segmental glomerulosclerosis
    2003
  78. Biganzoli Laura; Čufer Tanja; Bruning Peter; Coleman Robert E; Duchateau Luc; Rapoport Bernardo; Nooij Marianne; Delhaye Francois; Miles D; Sulkes Aaron
    Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial
    2003
  79. Takač Iztok
    Raziskava Breast cancer international research group - BCIRG 005
    [Study Breast cancer international research group - BCIRG 005]
    2003
  80. Černelč Peter
    Zdravljenje primarne plazmacelične levkemije
    [Treatment of primary plasma cell leukemia]
    2003
  81. Romih Rok; Veranič Peter; Jezernik Kristjan
    Appraisal of differentiation markers in urothelial cells
    2002
  82. Kovač Damjan
    Imunosupresijsko zdravljenje ledvičnih bolezni: neželeni učinki in sodelovanje internist - družinski zdravnik
    2003
  83. Koselj-Kajtna M; Koselj M; Rott T; Kandus A; Bren A
    Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis
    2002
  84. Borštnar Simona
    Klinični primer (ne-Hodgkinov limfom, difuzni, velikocelični, B celični): bolnica T. R., 47 let
    2002
  85. Jezeršek-Novaković Barbara
    Predstavitev bolnikov z malignimi limfomi
    2002
  86. Koprivec Daša; Jezernik Kristijan
    Cyclophosphamide metabolites perforate the apical plasma membranes of urothelial cells in rats
    2002
  87. Biganzoli L; Čufer T; Bruning P; Coleman R; Duchateau L; Calvert AH; Gamucci T; Twelves C; Fargeot P; Epelbaum R; Lohrisch C; Piccart MJ
    Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European organization for research and treatment of cancer 10961 multicenter phase III trial
    2002
  88. Brodowicz T; Beslija S; Červek J; Mršič-Krmpotič Z; Tchernozemsky I; Wiltschke C; Ghilezan N; Grgič M; Jassem J; Zielinski C
    Gemcitabine, epirubicin and paclitaxel (GET) vs. 5-fluoro-uracil, epirubicin and cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase iii trial of the Central European cooperative oncology group (CECOG)
    2001
  89. Biganzoli L; Bonnefoi H; Mauriac L; Čufer T; Kabanga-Ngalula E; Hebert D; Piccart M
    Cyclophosphamide (C) - Epirubicine (E) - Capecitabine (X) combination, CEX: a safe and active regimen in the treatment of locally advanced/inflammatory (LA/I) or large operable (LO) breast cancer (BC). An EORTC-IDBBC study
    2001
  90. International breast cancer study group J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial
    2002
  91. Koprivec Daša
    Celične in molekularno biološke spremembe urotelija sečnega mehurja podgan po enkratni aplikaciji ciklofosfamida
    2002
  92. Colleoni Marco; Gelber Shari; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
    2001
  93. Bonnefoi H; Biganzoli L; Čufer T; Mauriac L; Hamilton A; Schaefer P; Picart M
    An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer
    2001
  94. Thuerlimann B; Price KN; Castiglione M; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International breast cancer study group trial 11-93
    2001
  95. Zielinski C; Beslija S; Červek J; Mrsič-Krmpotič Z; Tchernozemsky I; Witschke C; Ghilezan N; Grgič M; Jassem J; Tzekova V
    Gemcitabine/Epirubicin/Paclitaxel (GET) vs. 5-Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase III trial of the central European cooperative oncology group (CECOG)
    2001
  96. Bonnefoi H; Biganzoli L; Mauriac L; Čufer T; Yague C; Hebert D; Piccart M
    An EORTC-IDBBC phase I study of cyclophosphamide (C) and epirubicin (E) in combination with capecitabine (X) (CEX) as primary treatment of locally advanced / inflammatory (LA/I) or large operable (LO) breast cancer (BC)
    2001
  97. Pohar-Marinšek Živa; Anžič Jožica; Jereb Berta
    Evolving strategies in the treatment of childhood rhabdomyosarcoma: Slovenian experience
    [Spremenjeni načini zdravljenja rabdomiosarkoma pri otrocih, slovenske izkušnje]
    2001
  98. Vodovnik A; Cerar A
    Synchronous herpes simplex virus and cytomegalovirus esophagitis
    2000
  99. Koprivec Daša; Romih Rok; Jezernik Kristijan
    The effect of cyclophosphamide on the apical plasma membrane of the urothelial cells in rats
    2001
  100. Koprivec Daša
    Apoptoza v uroteliju sečnega mehurja podgan po tretiranju s ciklofosfamidom
    [Apoptosis in urothelium of the rat urinary bladder after cyclophosphamide treatment]
    1999

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics